Purchase Order 36C25225P0649
Award Date
5/5/25
Potential Completion Date
5/9/25
Potential Value
$11K
Federal Agency
Veterans Integrated Service Network 12
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The $10,708.63 contract is for the emergency purchase of sodium oxybate, a medication used to treat certain medical conditions. The contract has a completion date of March 28, 2025 and is part of the VA's Veterans Integrated Service Network 12 (VISN 12) program, which...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) to Accredo Health Group, Inc., a for-profit pharmaceutical distributor. The contract, valued at $76,986.72, is for the delivery of the specialty medication "EMERGENCY LUMRYZ 9GM" with a period of performance ending on September 30, 2025. Accredo Health Group, Inc. is a subsidiary of Express Scripts and a key provider of complex and high-value...
This federal contract award to Accredo Health Group, Inc. for $307,946.88 was made on June 28, 2024 by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 20 (VISN 20). The contract is for the delivery of LUMRYZ 9GM/PKT (SODIUM OXYBATE 9GM/PKT GRNL,ECORAL) 30CT, a specialty pharmaceutical product utilized in VA treatment programs. As the prime contractor, Accredo Health Group will provide this medication directly to VA medical centers nationwide through a firm...
The U.S. Department of Veterans Affairs (VA) awarded a $43,162 firm fixed-price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical Prolastin. This contract is not associated with a set-aside program and has an ultimate completion date of June 30, 2024. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily serving the healthcare needs of...
The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...
This is a $81,632.25 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit subsidiary of Express Scripts that specializes in providing specialty pharmaceutical services. The contract is for the delivery of the medication Tyvaso, which is used to treat pulmonary arterial hypertension. The contract has no set-aside designation and was awarded on April 6, 2021, with a completion date of September 30, 2021....
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract to Accredo Health Group, Inc., a subsidiary of Express Scripts, to provide OXERVATE 0.002% OPTH DROPS 1 ML 7'S 7ML 2 PACK, a specialty pharmaceutical product. The $74,694.08 contract has an ultimate completion date of March 31, 2025 and was awarded on January 10, 2023 through the VA's Veterans Integrated Service Network 21 (VISN 21). The contract is not designated as a set-aside. Accredo Health Group,...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical product UPTRAVI. The $125,284.68 contract supports the delivery of this medication directly to VA medical centers and facilities across the country, including in Palo Alto, California. This order, which does not have a set-aside designation, is part of Accredo Health...